参考文献

［1］Chen H，He X，Wang Z，et al.Identification of human T cell receptor gammadelta-recognized epitopes/proteins via CDR3delta peptide-based immunobiochemical strategy.J Biol Chem.May 2 2008，283(18)：12528-12537.

［2］Dai Y，Chen H，Mo C，et al.Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human gammadelta T cells to induce innate anti-tumor/virus immunity.J Biol Chem.May 11 2012；287(20)：16812-16819.

［3］Mo C，Dai Y，Kang N，et al.Ectopic expression of human MutS homologue 2 on renal carcinoma cells is induced by oxidative stress with interleukin-18 promotion via p38 mitogen-activated protein kinase(MAPK)and c-Jun N-terminal kinase(JNK)signaling pathways.J Biol Chem.Jun 1 2012，287(23)：19242-19254.

［4］Chen H，Ji X，Cui L，et al.Characterization of complementary determinant region 3delta in human MutS homologue 2-specific gammadelta T cells.Scand J Immunol.Feb 2015，81(2)：121-128.

［5］Xi X，Zhang X，Wang B，et al.A novel strategy to screen Bacillus Calmette-Guerin protein antigen recognized by gammadelta TCR.PLoS One.2011，6(4)：e18809.

［6］Chen H，You H，Wang L，et al.Chaperonin-containing T-complex Protein 1 Subunit zeta Serves as an Autoantigen Recognized by HumanVdelta2 gammadelta T Cells in Autoimmune Diseases.J Biol Chem.Sep 16 2016，291(38)：19985-19993.

［7］Vavassori S，Kumar A，Wan GS，et al.Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells.Nat Immunol.Sep 2013，14(9)：908-916.

［8］Sandstrom A，Peigne CM，Leger A，et al.The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vgamma9Vdelta2 T cells.Immunity.Apr 17 2014，40(4)：490-500.

［9］Wang H，Morita CT.Sensor function for butyrophilin 3A1 in prenyl pyrophosphate stimulation of human vgamma2Vdelta2 T cells.J Immunol.Nov 15 2015，195(10)：4583-4594.

［10］Riano F，Karunakaran MM，Starick L，et al.Vgamma9Vdelta2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1(BTN3A1)and additional genes on human chromosome 6.Eur J Immunol.Sep 2014，44(9)：2571-2576.

［11］Rhodes DA，Chen HC，Price AJ，et al.Activation of human gammadelta T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.J Immunol.Mar 1 2015，194(5)：2390-2398.

［12］Sebestyen Z，Scheper W，Vyborova A，et al.RhoB mediates phosphoantigen recognition by vgamma9Vdelta2 T cell receptor.Cell Rep.May 31 2016，15(9)：1973-1985.

［13］Gruenbacher G，Gander H，Rahm A，et al.Ecto-ATPase CD39 inactivates isoprenoid-derived vgamma9Vdelta2 T cell phosphoantigens.Cell Rep.Jul 12 2016，16(2)：444-456.

［14］Kilcollins AM，Li J，Hsiao CH，et al.HMBPP analog prodrugs bypass energy-dependent uptake to promote efficient BTN3A1-mediated malignant cell lysis by vgamma9Vdelta2 T lymphocyte effectors.J Immunol.Jul 15 2016，197(2)：419-428.

［15］Pellicci DG，Uldrich AP，Le Nours J，et al.The molecular bases of delta/alphabeta T cell-mediated antigen recognition.J Exp Med.Dec 15 2014，211(13)：2599-2615.

［16］Roy S，Ly D，Castro CD，et al.Molecular analysis of lipid-reactive Vdelta1 gammadelta T cells identified by CD1c tetramers.J Immunol.Feb 15 2016，196(4)：1933-1942.

［17］Schwacha MG，Rani M，Nicholson SE，et al.Dermal gammadelta T-cells can be activated by mitochondrial damage-associated molecular patterns.PLoS One.2016，11(7)：e0158993.

［18］Schwacha MG，Rani M，Zhang Q，et al.Mitochondrial damage-associated molecular patterns activate gammadelta T-cells.Innate Immun.Apr 2014，20(3)：261-268.

［19］Shibata K，Yamada H，Nakamura M，et al.IFN-gamma-producing and IL-17-producing gammadelta T cells differentiate at distinct developmental stages in murine fetal thymus.J Immunol.Mar 1 2014，192(5)：2210-2218.

［20］Colpitts SL，Puddington L，Lefrancois L.IL-15 receptor alpha signaling constrains the development of IL-17-producing gammadelta T cells.Proc Natl Acad Sci U S A.Aug 4 2015，112(31)：9692-9697.

［21］Nitta T，Muro R，Shimizu Y，et al.The thymic cortical epithelium determines the TCR repertoire of IL-17-producing gammadeltaT cells.EMBO Rep.May 2015，16(5)：638-653.

［22］Buus TB，Schmidt JD，Bonefeld CM，et al.Development of interleukin-17-producing Vgamma2+gammadelta T cells is reduced by ICOS signaling in the thymus.Oncotarget.Apr 12 2016，7(15)：19341-19354.

［23］Nakamura M，Shibata K，Hatano S，et al.A genome-wide analysis identifies a notch-RBP-Jkappa-IL-7Ralpha axis that controls IL-17-producing gammadelta T cell homeostasis in mice.J Immunol.Jan 1 2015，194(1)：243-251.

［24］Lu Y，Cao X，Zhang X，et al.PLZF Controls the Development of Fetal-Derived IL-17+Vgamma6+gammadelta T Cells.J Immunol.Nov 1 2015，195(9)：4273-4281.

［25］Akitsu A，Ishigame H，Kakuta S，et al.IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vgamma6+gammadelta T cells.Nat Commun.2015，6：7464.

［26］Andersson A，Grahnemo L，Engdahl C，et al.IL-17-producing gammadeltaT cells are regulated by estrogen during development of experimental arthritis.Clin Immunol.Dec 2015，161(2)：324-332.

［27］Maeda Y，Seki N，Kataoka H，et al.IL-17-ProducingVgamma4+gammadelta T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.J Immunol.Aug 15 2015，195(4)：1408-1416.

［28］Sheel M，Beattie L，Frame TC，et al.IL-17A-Producing gammadelta T Cells Suppress Early Control of Parasite Growth by Monocytes in the Liver.J Immunol.Dec 15 2015，195(12)：5707-5717.

［29］Paget C，Chow MT，Gherardin NA，et al.CD3bright signals on gammadelta T cells identify IL-17A-producing Vgamma6Vdelta1+T cells.Immunol Cell Biol.Feb 2015，93(2)：198-212.

［30］Maher CO，Dunne K，Comerford R，et al.Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by Vdelta1 T cells.J Immunol.Jun 15 2015，194(12)：5953-5960.

［31］Ono T，Okamoto K，Nakashima T，et al.IL-17-producing gammadelta T cells enhance bone regeneration.Nat Commun.2016，7：10928.

［32］Rao R，Graffeo CS，Gulati R，et al.Interleukin 17-producing gammadeltaT cells promote hepatic regeneration in mice.Gastroenterology.Aug 2014，147(2)：473-484 e472.

［33］Nakajima S，Kitoh A，Egawa G，et al.IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models.J Invest Dermatol.Aug 2014，134(8)：2122-2130.

［34］Peng X，Xiao Z，Zhang J，et al.IL-17A produced by bothgammadelta T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction.J Pathol.Jan 2015，235(1)：79-89.

［35］Kimura Y，Nagai N，Tsunekawa N，et al.IL-17A-producing CD30+Vdelta1 T cells drive inflammation-induced cancer progression.Cancer Sci.Sep 2016，107(9)：1206-1214.

［36］Rei M，Goncalves-Sousa N，Lanca T，et al.Murine CD27-Vgamma6+gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages.Proc Natl Acad Sci U S A.Aug 26 2014，111(34)：E3562-3570.

［37］Ma S，Cheng Q，Cai Y，et al.IL-17A produced bygammadelta T cells promotes tumor growth in hepatocellular carcinoma.Cancer Res.Apr 1 2014，74(7)：1969-1982.

［38］Wu P，Wu D，Ni C，et al.gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer.Immunity.May 15 2014，40(5)：785-800.

［39］Coffelt SB，Kersten K，Doornebal CW，et al.IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis.Nature.Jun 18 2015，522(7556)：345-348.

［40］Tougaard P，Skov S，Pedersen AE，et al.TL1A regulates TCRgammadelta+intraepithelial lymphocytes and gut microbial composition.Eur J Immunol.Mar 2015，45(3)：865-875.

［41］Frossard CP，Asigbetse KE，Burger D，et al.Gut T cell receptor-gammadelta+intraepithelial lymphocytes are activated selectively by cholera toxin to break oral tolerance in mice.Clin Exp Immunol.Apr 2015，180(1)：118-130.

［42］Do J，Visperas A，Freeman ML，et al.gammadelta T cells support gut Ag-reactive colitogenic effector T-cell generation by enhancing Ag presentation by CD11b+DCs in the mesenteric LN.Eur J Immunol.Feb 2016，46(2)：340-346.

［43］Meehan TF，Witherden DA，Kim CH，et al.Protection against colitis by CD100-dependent modulation of intraepithelial gammadelta T lymphocyte function.Mucosal Immunol.Jan 2014，7(1)：134-142.

［44］Edelblum KL，Singh G，Odenwald MA，et al.gammadelta Intraepithelial Lymphocyte Migration Limits Transepithelial Pathogen Invasion and Systemic Disease in Mice.Gastroenterology.Jun 2015，148(7)：1417-1426.

［45］Lee JS，Tato CM，Joyce-Shaikh B，et al.Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.Immunity.Oct 20 2015，43(4)：727-738.

［46］Rezende RM，da Cunha AP，Kuhn C，et al.Identification and characterization of latency-associated peptide-expressing gammadelta T cells.Nat Commun.2015，6：8726.

［47］Ramirez-Valle F，Gray EE，Cyster JG.Inflammation induces dermal Vgamma4+gammadeltaT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses.Proc Natl Acad Sci U S A.Jun 30 2015，112(26)：8046-8051.

［48］Hartwig T，Pantelyushin S，Croxford AL，et al.Dermal IL-17-producing gammadelta T cells establish long-lived memory in the skin.Eur J Immunol.Nov 2015，45(11)：3022-3033.

［49］Sulcova J，Maddaluno L，Meyer M，et al.Accumulation and activation of epidermal gammadelta T cells in a mouse model of chronic dermatitis is not required for the inflammatory phenotype.Eur J Immunol.Sep 2015，45(9)：2517-2528.

［50］Han J，Lee E，Kim E，et al.Role of epidermalgammadelta T-cell-derived interleukin 13 in the skin-whitening effect of Ginsenoside F1.Exp Dermatol.Nov 2014，23(11)：860-862.

［51］MacLeod AS，Rudolph R，Corriden R，et al.Skin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair.J Immunol.Jun 15 2014，192(12)：5695-5702.

［52］Ujiie H，Shevach EM.gammadelta T Cells Protect the Liver and Lungs of Mice from Autoimmunity Induced by Scurfy Lymphocytes.J Immunol.Feb 15 2016，196(4)：1517-1528.

［53］Klemann C，Schroder A，Dreier A，et al.Interleukin 17，Produced by gammadelta T Cells，Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and Is Increased in Livers of Patients.Gastroenterology.Jan 2016，150(1)：229-241 e225.

［54］Hammerich L，Bangen JM，Govaere O，et al.Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis.Hepatology.Feb 2014，59(2)：630-642.

［55］Wanke-Jellinek L，Keegan JW，Dolan JW，et al.Characterization of lung infection-induced TCRgammadelta T cell phenotypes by CyTOF mass cytometry.J Leukoc Biol.Mar 2016，99(3)：483-493.

［56］Wehrmann F，Lavelle JC，Collins CB，et al.gammadelta T cells protect against LPS-induced lung injury.J Leukoc Biol.Feb 2016，99(2)：373-386.

［57］Costa MF，de Negreiros CB，Bornstein VU，et al.Murine IL-17+Vgamma4 T lymphocytes accumulate in the lungs and play a protective role during severe sepsis.BMC Immunol.2015，16：36.

［58］Hu YM，Yeh CL，Pai MH，et al.Glutamine administration modulates lunggammadelta T lymphocyte expression in mice with polymicrobial sepsis.Shock.Feb 2014，41(2)：115-122.

［59］Zhou J，Kang N，Cui L，et al.Anti-gammadelta TCR antibody-expanded gammadelta T cells：a better choice for the adoptive immunotherapy of lymphoid malignancies.Cell Mol Immunol.Jan 2012，9(1)：34-44.

［60］He X，Chen H，Wu D，et al.Tandem-epitope peptide：a novel stimulator forgammadeltaT cells in tumor immunotherapy.Cancer Lett.Feb 1 2010，288(1)：86-93.

［61］Wang Z，Zhang T，Hu H，et al.Targeting solid tumors via T cell receptor complementarity-determining region 3delta in an engineered antibody.Cancer Lett.Dec 18 2008，272(2)：242-252.

［62］Zheng J，Guo Y，Ji X，et al.A novel antibody-like TCRgammadelta-Ig fusion protein exhibits antitumor activity against human ovarian carcinoma.Cancer Lett.Dec 1 2013，341(2)：150-158.

［63］Zhao H，Xi X，Cui L，et al.CDR3delta-grafted gamma9delta2T cells mediate effective antitumor reactivity.Cell Mol Immunol.Mar 2012，9(2)：147-154.

［64］He K，You H，Li Y，et al.TCRgamma4delta1-engineered alphabetaT cells exhibit effective antitumor activity.Mol Med.Jul 26 2016，22.

［65］Arkko S，Zlatev HP，Monkkonen H，et al.Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vgamma9Vdelta2 T cell cytotoxicity in PC-3 prostate cancer cells.Cancer Lett.Feb 1 2015，357(1)：279-285.

［66］Parente-Pereira AC，Shmeeda H，Whilding LM，et al.Adoptive immunotherapy of epithelial ovarian cancer with Vgamma9Vdelta2 T cells，potentiated by liposomal alendronic acid.J Immunol.Dec 1 2014，193(11)：5557-5566.

［67］Sugai S，Yoshikawa T，Iwama T，et al.Hepatocellular carcinoma cell sensitivity to Vgamma9Vdelta2 T lymphocyte-mediated killing is increased by zoledronate.Int J Oncol.May 2016，48(5)：1794-1804.

［68］Di Carlo E，Bocca P，Emionite L，et al.Mechanisms of the antitumor activity of human Vgamma9Vdelta2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.Mol Ther.May 2013，21(5)：1034-1043.

［69］Jarry U，Chauvin C，Joalland N，et al.Stereotaxic administrations of allogeneic human Vgamma9Vdelta2 T cells efficiently control the development of human glioblastoma brain tumors.Oncoimmunology.Jun 2016，5(6)：e1168554.

［70］Santolaria T，Robard M，Leger A，et al.Repeated systemic administrations of both aminobisphosphonates and human Vgamma9Vdelta2 T cells efficiently control tumor development in vivo.J Immunol.Aug 15 2013，191(4)：1993-2000.

［71］Duault C，Franchini DM，Familliades J，et al.TCRVgamma9 gammadelta T Cell Response to IL-33：A CD4 T Cell-Dependent Mechanism.J Immunol.Jan 1 2016，196(1)：493-502.

［72］Yoshikawa T，Takahara M，Tomiyama M，et al.Large-scale expansion of gammadelta T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.Int J Oncol.Nov 2014，45(5)：1847-1856.

［73］de Bruin RC，Lougheed SM，van der Kruk L，et al.Highly specific and potently activating Vgamma9Vdelta2-T cell specific nanobodies for diagnostic and therapeutic applications.Clin Immunol.Aug 2016，169：128-138.

［74］Wu D，Wu P，Wu X，et al.Ex vivo expanded human circulating Vdelta1 gammadelta T cells exhibit favorable therapeutic potential for colon cancer.Oncoimmunology.Mar 2015，4(3)：e992749.

［75］Almeida AR，Correia DV，Fernandes-Platzgummer A，et al.Delta One T cells for immunotherapy of chronic lymphocytic leukemia：clinical-grade expansion/differentiation and preclinical proof-of-concept.Clin Cancer Res.Jun 15 2016.

［76］Fisher JP，Yan M，Heuijerjans J，et al.Neuroblastoma killing properties of Vdelta2 and Vdelta2-negative gammadelta T cells following expansion by artificial antigen-presenting cells.Clin Cancer Res.Nov 15 2014，20(22)：5720-5732.

［77］Deniger DC，Maiti SN，Mi T，et al.Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.Clin Cancer Res.Nov 15 2014，20(22)：5708-5719.

［78］Deniger DC，Switzer K，Mi T，et al.Bispecific T-cells expressing polyclonal repertoire of endogenous gammadelta T-cell receptors and introduced CD19-specific chimeric antigen receptor.Mol Ther.Mar 2013，21(3)：638-647.

［79］Bhat J，Kabelitz D.gammadelta T cells and epigenetic drugs：A useful merger in cancer immunotherapy?Oncoimmunology.Jun 2015，4(6)：e1006088.

［80］Gonnermann D，Oberg HH，Kellner C，et al.Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against gammadelta T cell cytotoxicity.Oncoimmunology.Mar 2015，4(3)：e988460.

［81］Lamb LS，Jr.，Bowersock J，Dasgupta A，et al.Engineered drug resistant gammadelta T cells kill glioblastoma cell lines during a chemotherapy challenge：a strategy for combining chemo-and immunotherapy.PLoS One.2013，8(1)：e51805.

［82］Chitadze G，Lettau M，Luecke S，et al.NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human gammadelta T cells：Modulation bytemozolomide and A disintegrin and metalloproteases10 and 17 inhibitors.Oncoimmunology.Apr 2016，5(4)：e1093276.

［83］Fisher JP，Flutter B，Wesemann F，et al.Effective combination treatment of GD2-expressing neuroblastoma and Ewing’s sarcoma using anti-GD2 ch14.18/CHO antibody with Vgamma9Vdelta2+gammadelta T cells.Oncoimmunology.2016，5(1)：e1025194.

［84］Daley D，Zambirinis CP，Seifert L，et al.gammadelta T Cells Support Pancreatic Oncogenesis by Restraining alphabeta T Cell Activation.Cell.Sep 8 2016，166(6)：1485-1499 e1415.

［85］Huang Y，Heiser RA，Detanico TO，et al.gammadelta T cells affect IL-4 production and B-cell tolerance.Proc Natl Acad Sci U S A.Jan 6 2015，112(1)：E39-48.

［86］Huang Y，Getahun A，Heiser RA，et al.gammadelta T Cells Shape Preimmune Peripheral B Cell Populations.J Immunol.Jan 1 2016，196(1)：217-231.

［87］Mathews JA，Kasahara DI，Ribeiro L，et al.gammadelta T Cells Are Required for M2 Macrophage Polarization and Resolution of Ozone-Induced Pulmonary Inflammation in Mice.PLoS One.2015，10(7)：e0131236.

［88］Huang Y，Yang Z，Huang C，et al.gammadelta T Cell-Dependent Regulatory T Cells Prevent the Development of Autoimmune Keratitis.J Immunol.Dec 15 2015，195(12)：5572-5581.

［89］Rani M，Zhang Q，Schwacha MG.Gamma delta T cells regulate wound myeloid cell activity after burn.Shock.Aug 2014，42(2)：133-141.

［90］Rani M，Zhang Q，Oppeltz RF，et al.Gamma delta T cells regulate inflammatory cell infiltration of the lung after trauma-hemorrhage.Shock.Jun 2015，43(6)：589-597.

［91］Long KM，Ferris MT，Whitmore AC，et al.gammadelta T Cells Play a Protective Role in Chikungunya Virus-Induced Disease.J Virol.Jan 2016，90(1)：433-443.

［92］Soriano-Sarabia N，Archin NM，Bateson R，et al.Peripheral Vgamma9Vdelta2 T Cells Are a Novel Reservoir of Latent HIV Infection.PLoS Pathog.Oct 2015，11(10)：e1005201.

［93］Daguzan C，Moulin M，Kulyk-Barbier H，et al.Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vgamma9Vdelta2 Cells.J Immunol.Mar 1 2016，196(5)：2219-2229.

［94］Kaminski H，Garrigue I，Couzi L，et al.Surveillance of gammadelta T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants.J Am Soc Nephrol.Feb 2016，27(2)：637-645.

［95］Sell S，Dietz M，Schneider A，et al.Control of murine cytomegalovirus infection by gammadelta T cells.PLoS Pathog.Feb 2015，11(2)：e1004481.

［96］Khairallah C，Netzer S，Villacreces A，et al.gammadelta T cells confer protection against murine cytomegalovirus(MCMV).PLoS Pathog.Mar 2015，11(3)：e1004702.

［97］Blink SE，Caldis MW，Goings GE，et al.gammadelta T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.Cell Immunol.Jul 2014，290(1)：39-51.

［98］Perko R，Kang G，Sunkara A，et al.Gamma delta T cell reconstitution is associated with fewer infections and improved eventfree survival after hematopoietic stem cell transplantation for pediatric leukemia.Biol Blood Marrow Transplant.Jan 2015，21(1)：130-136.

［99］Dimova T，Brouwer M，Gosselin F，et al.Effector Vgamma9Vdelta2 T cells dominate the human fetal gammadelta T-cell repertoire.Proc Natl Acad Sci U S A.Feb 10 2015，112(6)：E556-565.

［100］Jagannathan P，Kim CC，Greenhouse B，et al.Loss and dysfunction of Vdelta2+gammadelta T cells are associated with clinical tolerance to malaria.Sci Transl Med.Aug 27 2014，6(251)：251ra117.

［101］Farrington LA，Jagannathan P，McIntyre TI，et al.Frequent Malaria Drives Progressive Vdelta2 T-Cell Loss，Dysfunction，and CD16 Up-regulation During Early Childhood.J Infect Dis.May 1 2016，213(9)：1483-1490.

［102］Tan CT，Wistuba-Hamprecht K，Xu W，et al.Vdelta2+and alpha/ss T cells show divergent trajectories during human aging.Oncotarget.Jun 15 2016.

［103］McGill JL，Sacco RE，Baldwin CL，et al.Specific recognition of mycobacterial protein and peptide antigens by gammadelta T cell subsets following infection with virulent Mycobacterium bovis.J Immunol.Mar 15 2014，192(6)：2756-2769.

［104］Peckham RK，Brill R，Foster DS，et al.Two distinct populations of bovine IL-17+T-cells can be induced and WC1+IL-17+gammadelta T-cells are effective killers of protozoan parasites.Sci Rep.2014，4：5431.

［105］Guzman E，Hope J，Taylor G，et al.Bovinegammadelta T cells are a major regulatory T cell subset.J Immunol.Jul 1 2014，193(1)：208-222.

［106］Hsu H，Baldwin CL，Telfer JC.The endocytosis and signaling of thegammadelta T cell coreceptor WC1 are regulated by a dileucine motif.J Immunol.Mar 1 2015，194(5)：2399-2406.